FDA Import Refusal BHC-5003124-2/12/1 — GlaxoSmithKline LLC
The FDA refused shipment BHC-5003124-2/12/1 from GlaxoSmithKline LLC (United States) on Aug 21, 2009. The refused product falls under Drugs and Biologics — ROSIGLITAZONE MALEATE/METFORMIN HCI. Cited charge: 179 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Aug 21, 2009
- Country
- United States
- Product Category
- Drugs and Biologics
- Product Code
- 61PDA61 ROSIGLITAZONE MALEATE/METFORMIN HCI
- Charges
- 179